1CE0.F Vitura Health Limited
- Market cap
- EUR 6.63M
- P/E
- -
- P/B
- 0.25x
- ROE
- -10.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 1CE0.F undervalued?
Graham numberThe Graham number of Vitura Health Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Vitura Health Limited fundamental analysis
No fundamental analysis for Vitura Health Limited yet.
Vitura Health Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Vitura Health Limited
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which …
Full company profileVitura Health Limited financial statements
Vitura Health Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 67.0M | 117M | 124M | 124M | 131M |
| Gross Profit | 25.4M | 40.5M | 34.2M | 33.8M | 28.4M |
| Operating Income | 9.24M | 19.9M | 4.87M | 5.24M | -2.01M |
| EBITDA | 10.9M | 21.3M | 7.25M | 7.84M | -412K |
| Net Income | 6.05M | 13.8M | 3.51M | 3.32M | -4.39M |
| EPS | 0.01 | 0.02 | 0.01 | 0.01 | -0.01 |
| Balance Sheet | |||||
| Total Assets | 42.9M | 46.9M | 71.3M | 75.5M | 76.7M |
| Total Liabilities | 16.8M | 12.0M | 32.8M | 27.9M | 33.8M |
| Shareholders' Equity | 26.1M | 35.0M | 38.8M | 48.2M | 43.5M |
| Cash & Short-term Investments | 16.1M | 18.8M | 11.3M | 7.58M | 5.35M |
| Cash Flow | |||||
| Capital Expenditure | 377K | 928K | 786K | 4.52M | 2.43M |
| Free Cash Flow | 13.1M | 8.78M | 6.21M | -1.85M | -2.52M |
| Ratios | |||||
| ROE | 23.2% | 39.5% | 9.1% | 6.9% | -10.1% |
| ROA | 14.1% | 29.4% | 4.9% | 4.4% | -5.7% |
| Net Profit Margin | 9.0% | 11.8% | 2.8% | 2.7% | -3.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Vitura Health Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Sep 5, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 1.29M | 0.00 | - |
| 2025 | - | - | - |
| 2024 | AUD 5.44M | 0.01 | 154.8% |
| 2023 | AUD 5.46M | 0.01 | 39.6% |
| 2022 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Vitura Health Limited
- Insiders 72.01%
- Institutions 1.28%
- Public & others 26.71%
- Shares outstanding 663M
- Free float 230M
Vitura Health Limited company profile
- Company name
- Vitura Health Limited
- Ticker
- 1CE0.F
- ISIN
- AU0000266801
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- June
- Address
- Suite 21, Level 3, South Yarra, VIC, Australia, 3141
- Phone
- 59 6 2907 1594
- Website
- vitura.com.au
About Vitura Health Limited
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya, which provides hybrid formulations and Australian-cultivated products; Candor Medical, that provides care to patients; and inscape, which offers crafted formulations for individual needs. In addition, the company engages in the supply of MDMA and synthetic psilocybin for therapeutic purposes. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.
Vitura Health Limited management
5- Mr. Justin D. JamesChief Executive Officer
- Mr. James FrayneChief Financial Officer
- Ms. Trudy AdamsExecutive General Manager of Strategy, Technology & Risk
- Ms. Deanna JohnsExecutive GM of People & Culture
- Mr. Michael Sapountzis AGIA, B.Com., L.L.B., M.A.I.C.D.Company Secretary